Houlihan Lokey, Inc. (HLI) · Oct 28, 2026 · Earnings
Beat — GAAP EPS $1.64 vs ~$1.63 consensus; revenue $692M vs ~$625.9M consensus
Houlihan Lokey earnings beat revenue expectations as Corporate Finance recovered, though fewer closed deals and weaker restructuring temper the quarter.
Houlihan Lokey is a global investment bank building around three cyclical advisory engines: M&A and capital markets, financial restructuring, and valuation and financial advisory. Its standing story entering this quarter was a recovery in M&A activity alongside persistent uncertainty from rates, geopolitics, trade policy, and leverage; the company has also described restructuring demand as stable but uneven.
The quarter beat expectations decisively on revenue. Revenue reached $692 million versus $660 million a year earlier, well above the published consensus of roughly $625.9 million, while GAAP diluted EPS was $1.64 versus roughly $1.63 expected. Adjusted EPS was $1.85 versus $1.84 a year earlier. (Financial Highlights; Reconciliation of GAAP to Adjusted Financial Information) The beat is especially meaningful after the prior quarter's earnings miss, although the exact consensus benchmark is an external estimate.
| Metric | Q2 FY2027 | Q2 FY2026 / expectation | Read-through |
|---|---|---|---|
| Revenue | $692M | $660M prior year; ~$625.9M consensus | Large beat (Financial Highlights) |
| GAAP diluted EPS | $1.64 | $1.63 prior year; ~$1.63 consensus | Narrow beat (Financial Highlights) |
| Adjusted diluted EPS | $1.85 | $1.84 prior year | Essentially flat year over year (Reconciliation of GAAP to Adjusted Financial Information) |
| Corporate Finance revenue | $481M | $439M prior year | +10% (Segment results — Corporate Finance) |
| Financial Restructuring revenue | $118M | $134M prior year | -12% (Segment results — Financial Restructuring) |
| FVA revenue | $93M | $87M prior year | +7% (Segment results — Financial and Valuation Advisory) |
| Six-month revenue | $1.203B | $1.265B prior year | Still down 5% year to date (Financial Highlights) |
| Quarterly dividend | $0.70/share | $0.70 declared | No change (Capital returns) |
M&A is carrying the recovery, but the quality of the rebound is mixed. Corporate Finance revenue rose 10% because average fees increased with transaction mix and better M&A and capital-markets conditions, even as closed transactions fell to 142 from 171. 〔0〕 (Segment results — Corporate Finance) That means the quarter's revenue upside came more from larger or richer assignments than from a broad increase in deal volume. The company's 267 Corporate Finance managing directors, up from 242, also show that capacity has been added ahead of a fuller transaction recovery. (Segment results — Corporate Finance)
Restructuring remains the drag on the broader business. Financial Restructuring revenue declined 12%, with closed transactions falling to 27 from 37, while the six-month segment decline was even steeper at 10%. Management attributes the quarterly drop to closing timing, so this is not necessarily a structural deterioration, but it keeps the recovery uneven rather than broad-based. 〔1〕 (Segment results — Financial Restructuring)
Profitability held up better than the headline mix suggests. GAAP operating income increased modestly to $154 million from $151 million, while the adjusted compensation ratio stayed at 61.5%. However, adjusted non-compensation expense rose to 13.3% of revenue from 12.5%, and the six-month adjusted operating income was $272 million versus $310 million a year earlier. This is a revenue beat, not yet a clean acceleration in underlying earnings power. (Expense analysis; Reconciliation of GAAP to Adjusted Financial Information)
Capital returns remain intact despite lower year-to-date cash. The company declared its regular $0.70 quarterly dividend and repurchased 397,000 shares during the quarter; cash and investment securities totaled $888 million at September 30, 2026. (Capital returns) This supports the financial position but is a continuation of the existing policy, not a new catalyst.
Bottom line: This was a clear revenue beat and a useful confirmation that M&A conditions are improving, but the recovery still depends on fee mix and larger assignments while restructuring remains soft. The business story improved this quarter, though the six-month numbers show it is not yet a broad-based earnings acceleration.
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!